Evidence map›Paper›PMID 20618946›Full record

ArticleMolecular cancer2010

TLX1 and NOTCH coregulate transcription in T cell acute lymphoblastic leukemia cells.

Irene Riz, Teresa S Hawley, Truong V Luu, Norman H Lee, Robert G Hawley

Open access · goldAbstract read
In one paragraph

Article in Molecular cancer, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Genome-Wide Analysis IdentifiesFrontiers in cell and developmental biology · 2021
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Upregulation of T-Cell-Specific Transcription Factor Expression in Pediatric T-Cell Acute Lymphoblastic Leukemia (T-ALL).Turkish journal of haematology : official journal of Turkish Society of Haematology · 2012
    Article
  19. Review
  20. Apoptotic role of IKK in T-ALL therapeutic response.Molecular cancer research : MCR · 2011
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Irene RizDepartment of Anatomy and Regenerative Biology, The George Washington University Medical Center, Washington, DC, USA.
Teresa S Hawley
Truong V Luu
Norman H Lee
Robert G Hawley
George Washington University · USWashington University Medical Center · US

Funding

Molecular Chimerism Therapy for Hemophilia AR01HL065519 · NHLBI · GEORGE WASHINGTON UNIVERSITY · PI HAWLEY, ROBERT G. · 2001 to 2009
$3.0M
Embryoid Body-derived Hematopoietic Stem Cell LinesR01HL066305 · NHLBI · GEORGE WASHINGTON UNIVERSITY · PI HAWLEY, ROBERT G. · 2001 to 2005
$1.7M
Mapping Gene Networks in Colon CancerR01CA120316 · NCI · GEORGE WASHINGTON UNIVERSITY · PI LEE, NORMAN H · 2007 to 2010
$1.6M
NCI NIH HHS R01CA120316NHLBI NIH HHS R01HL65519NHLBI NIH HHS R01HL66305
6 · The paper itself

Abstract

backgroundThe homeobox gene TLX1 (for T-cell leukemia homeobox 1, previously known as HOX11) is inappropriately expressed in a major subgroup of T cell acute lymphoblastic leukemia (T-ALL) where it is strongly associated with activating NOTCH1 mutations. Despite the recognition that these genetic lesions cooperate in leukemogenesis, there have been no mechanistic studies addressing how TLX1 and NOTCH1 functionally interact to promote the leukemic phenotype.

resultsGlobal gene expression profiling after downregulation of TLX1 and inhibition of the NOTCH pathway in ALL-SIL cells revealed that TLX1 synergistically regulated more than 60% of the NOTCH-responsive genes. Structure-function analysis demonstrated that TLX1 binding to Groucho-related TLE corepressors was necessary for maximal transcriptional regulation of the NOTCH-responsive genes tested, implicating TLX1 modulation of the NOTCH-TLE regulatory network. Comparison of the dataset to publicly available biological databases indicated that the TLX1/NOTCH-coregulated genes are frequently targeted by MYC. Gain- and loss-of-function experiments confirmed that MYC was an essential mediator of TLX1/NOTCH transcriptional output and growth promotion in ALL-SIL cells, with TLX1 contributing to the NOTCH-MYC regulatory axis by posttranscriptional enhancement of MYC protein levels. Functional classification of the TLX1/NOTCH-coregulated targets also showed enrichment for genes associated with other human cancers as well as those involved in developmental processes. In particular, we found that TLX1, NOTCH and MYC coregulate CD1B and RAG1, characteristic markers of early cortical thymocytes, and that concerted downregulation of the TLX1 and NOTCH pathways resulted in their irreversible repression.

conclusionsWe found that TLX1 and NOTCH synergistically regulate transcription in T-ALL, at least in part via the sharing of a TLE corepressor and by augmenting expression of MYC. We conclude that the TLX1/NOTCH/MYC network is a central determinant promoting the growth and survival of TLX1+ T-ALL cells. In addition, the TLX1/NOTCH/MYC transcriptional network coregulates genes involved in T cell development, such as CD1 and RAG family members, and therefore may prescribe the early cortical stage of differentiation arrest characteristic of the TLX1 subgroup of T-ALL.

Indexed as

Cell DivisionGene Expression ProfilingGene Expression Regulation, NeoplasticHomeodomain ProteinsHumansPrecursor T-Cell Lymphoblastic Leukemia-LymphomaProto-Oncogene ProteinsReceptors, NotchTranscription, GeneticHomeodomain ProteinsProto-Oncogene ProteinsReceptors, NotchTLX1 protein, human

Identifiers

PMID20618946
PMCPMC2913983
OpenAlexW2161105679

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.